Log in

AstraZeneca News Headlines (NYSE:AZN)

$42.47
+0.11 (+0.26 %)
(As of 03/29/2020 03:02 AM ET)
Today's Range
$40.69
Now: $42.47
$43.13
50-Day Range
$37.79
MA: $45.58
$50.17
52-Week Range
$36.15
Now: $42.47
$51.55
Volume6.78 million shs
Average Volume6.40 million shs
Market Capitalization$111.46 billion
P/E Ratio80.13
Dividend Yield4.39%
Beta0.56

Headlines

AstraZeneca (NYSE AZN) News Headlines

Source:
DateHeadline
AstraZeneca plc (NYSE:AZN) Short Interest UpdateAstraZeneca plc (NYSE:AZN) Short Interest Update
www.americanbankingnews.com - March 27 at 10:43 AM
Cipla Receives Final Approval for Generic Version of AstraZeneca Pharmaceuticals Nexium® (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg) - PRNewswireCipla Receives Final Approval for Generic Version of AstraZeneca Pharmaceutical's Nexium® (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg) - PRNewswire
www.prnewswire.com - March 27 at 9:47 AM
AstraZenecas Lokelma Gets Approval in Japan for Hyperkalaemia - Yahoo FinanceAstraZeneca's Lokelma Gets Approval in Japan for Hyperkalaemia - Yahoo Finance
finance.yahoo.com - March 26 at 5:56 PM
AstraZeneca's Lokelma Gets Approval in Japan for HyperkalaemiaAstraZeneca's Lokelma Gets Approval in Japan for Hyperkalaemia
finance.yahoo.com - March 26 at 5:56 PM
BRIEF-Cipla Ltd -Gets Final Approval For Generic Version Of Astrazeneca Pharmas Nexium - ReutersBRIEF-Cipla Ltd -Gets Final Approval For Generic Version Of Astrazeneca Pharma's Nexium - Reuters
www.reuters.com - March 26 at 7:56 AM
BRIEF-AstraZeneca Says Lokelma Approved In Japan For Hyperkalaemia - ReutersBRIEF-AstraZeneca Says Lokelma Approved In Japan For Hyperkalaemia - Reuters
www.reuters.com - March 26 at 7:56 AM
As the stock market crash continues, I’d buy these 2 FTSE 100 stocks in an ISA right nowAs the stock market crash continues, I’d buy these 2 FTSE 100 stocks in an ISA right now
www.fool.co.uk - March 25 at 2:40 PM
Alongside AstraZeneca, I’d buy this small-cap share in the pharmaceutical sector - Yahoo Finance UKAlongside AstraZeneca, I’d buy this small-cap share in the pharmaceutical sector - Yahoo Finance UK
uk.finance.yahoo.com - March 25 at 9:38 AM
BRIEF-Brightinsight Announces Global Digital Health Partnership With AstraZeneca - ReutersBRIEF-Brightinsight Announces Global Digital Health Partnership With AstraZeneca - Reuters
www.reuters.com - March 25 at 9:38 AM
BRIEF-Silence Therapeutics Says Collaborating With Astrazeneca On siRNA Therapeutics - ReutersBRIEF-Silence Therapeutics Says Collaborating With Astrazeneca On siRNA Therapeutics - Reuters
www.reuters.com - March 25 at 9:38 AM
BrightInsight Announces Global Digital Health Partnership with AstraZeneca - Yahoo FinanceBrightInsight Announces Global Digital Health Partnership with AstraZeneca - Yahoo Finance
finance.yahoo.com - March 25 at 9:38 AM
Collaboration with AstraZeneca - Yahoo FinanceCollaboration with AstraZeneca - Yahoo Finance
finance.yahoo.com - March 25 at 9:38 AM
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - March 24, 2020How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - March 24, 2020
finance.yahoo.com - March 24 at 1:08 PM
AstraZeneca (AZN) to Donate 9 Million Face Masks, Italy to Receive First Shipment - StreetInsider.comAstraZeneca (AZN) to Donate 9 Million Face Masks, Italy to Receive First Shipment - StreetInsider.com
www.streetinsider.com - March 24 at 8:00 AM
Global COPD Drug Delivery Devices Market (2019 to 2027) - Featuring AstraZeneca, Boehringer Ingelheim & Novartis Among Others - GlobeNewswireGlobal COPD Drug Delivery Devices Market (2019 to 2027) - Featuring AstraZeneca, Boehringer Ingelheim & Novartis Among Others - GlobeNewswire
www.globenewswire.com - March 24 at 8:00 AM
AstraZeneca (NYSE:AZN) Getting Somewhat Negative Press Coverage, Analysis FindsAstraZeneca (NYSE:AZN) Getting Somewhat Negative Press Coverage, Analysis Finds
www.americanbankingnews.com - March 21 at 11:25 AM
Stock Traders Buy High Volume of AstraZeneca Call Options (NYSE:AZN)Stock Traders Buy High Volume of AstraZeneca Call Options (NYSE:AZN)
www.americanbankingnews.com - March 20 at 12:04 PM
If You Had Bought AstraZeneca (LON:AZN) Stock Five Years Ago, You Could Pocket A 47% Gain Today - Yahoo FinanceIf You Had Bought AstraZeneca (LON:AZN) Stock Five Years Ago, You Could Pocket A 47% Gain Today - Yahoo Finance
finance.yahoo.com - March 20 at 7:41 AM
If You Had Bought AstraZeneca (LON:AZN) Stock Five Years Ago, You Could Pocket A 47% Gain TodayIf You Had Bought AstraZeneca (LON:AZN) Stock Five Years Ago, You Could Pocket A 47% Gain Today
finance.yahoo.com - March 20 at 7:41 AM
Heres why Astrazeneca (LON:AZN) might cut its dividend paymentHere's why Astrazeneca (LON:AZN) might cut its dividend payment
uk.finance.yahoo.com - March 19 at 2:46 PM
AstraZenecas Imfinzi extends survival in first-line lung cancerAstraZeneca's Imfinzi extends survival in first-line lung cancer
seekingalpha.com - March 19 at 2:46 PM
Alongside GlaxoSmithKline and AstraZeneca, Id invest in this healthcare share - Motley Fool UKAlongside GlaxoSmithKline and AstraZeneca, I'd invest in this healthcare share - Motley Fool UK
www.fool.co.uk - March 18 at 7:45 AM
AstraZenecas lung cancer treatment fails to meet main goal - ReutersAstraZeneca's lung cancer treatment fails to meet main goal - Reuters
www.reuters.com - March 17 at 4:37 AM
Brain Tumor Treatment Market SWOT analysis & Key Business Strategies | The Biggest Opportunity Of 2020 | Roche Holding, AstraZeneca, PfizerBrain Tumor Treatment Market SWOT analysis & Key Business Strategies | The Biggest Opportunity Of 2020 | Roche Holding, AstraZeneca, Pfizer
www.marketwatch.com - March 16 at 7:18 AM
Global Obesity Market Outlook 2020-2026 - Astrazeneca has the Highest Number of Completed Clinical Trials, Sitting at 76 - Yahoo FinanceGlobal Obesity Market Outlook 2020-2026 - Astrazeneca has the Highest Number of Completed Clinical Trials, Sitting at 76 - Yahoo Finance
finance.yahoo.com - March 13 at 7:37 PM
AstraZeneca/Mercks Lynparza Combo Ovarian Cancer Study Fails - NasdaqAstraZeneca/Merck's Lynparza Combo Ovarian Cancer Study Fails - Nasdaq
www.nasdaq.com - March 13 at 7:37 PM
Should You Buy AstraZeneca plc (AZN)? - Yahoo FinanceShould You Buy AstraZeneca plc (AZN)? - Yahoo Finance
finance.yahoo.com - March 13 at 2:37 PM
Global Obesity Market Outlook 2020-2026 - Astrazeneca has the Highest Number of Completed Clinical Trials, Sitting at 76 - GlobeNewswireGlobal Obesity Market Outlook 2020-2026 - Astrazeneca has the Highest Number of Completed Clinical Trials, Sitting at 76 - GlobeNewswire
www.globenewswire.com - March 13 at 7:16 AM
Global Post-traumatic Stress Disorder (PSTD) Therapeutics Market 2020-2024 | Evolving Opportunities with AstraZeneca Plc and Azevan Pharmaceuticals Inc. | Technavio - Yahoo FinanceGlobal Post-traumatic Stress Disorder (PSTD) Therapeutics Market 2020-2024 | Evolving Opportunities with AstraZeneca Plc and Azevan Pharmaceuticals Inc. | Technavio - Yahoo Finance
finance.yahoo.com - March 10 at 12:32 PM
Does AstraZenecas share price fall make it a bargain FTSE 100 stock? - Motley Fool UKDoes AstraZeneca's share price fall make it a bargain FTSE 100 stock? - Motley Fool UK
www.fool.co.uk - March 10 at 7:32 AM
First Patient Dosed in IPH5201 Phase I Clinical Trial in Advanced Solid TumorsFirst Patient Dosed in IPH5201 Phase I Clinical Trial in Advanced Solid Tumors
finance.yahoo.com - March 10 at 7:32 AM
Global Post-traumatic Stress Disorder (PSTD) Therapeutics Market 2020-2024 | Evolving Opportunities with AstraZeneca Plc and Azevan Pharmaceuticals Inc. | Technavio - Business WireGlobal Post-traumatic Stress Disorder (PSTD) Therapeutics Market 2020-2024 | Evolving Opportunities with AstraZeneca Plc and Azevan Pharmaceuticals Inc. | Technavio - Business Wire
www.businesswire.com - March 9 at 4:24 AM
World Vaccines Market Outlook to 2030: Major Players are AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck and Pfizer - PRNewswireWorld Vaccines Market Outlook to 2030: Major Players are AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck and Pfizer - PRNewswire
www.prnewswire.com - March 5 at 3:48 PM
AstraZeneca plc (NYSE:AZN) Receives Consensus Recommendation of "Hold" from AnalystsAstraZeneca plc (NYSE:AZN) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 5 at 2:39 PM
Baron & Budd Moves Forward with False Claims Act Case Against AstraZeneca LP - Business WireBaron & Budd Moves Forward with False Claims Act Case Against AstraZeneca LP - Business Wire
www.businesswire.com - March 5 at 10:47 AM
Global Anesthetics Market Outlook 2020-2030 with Baxter, Abbott Laboratories, AstraZeneca, Roche, and B. Braun Dominating - GlobeNewswireGlobal Anesthetics Market Outlook 2020-2030 with Baxter, Abbott Laboratories, AstraZeneca, Roche, and B. Braun Dominating - GlobeNewswire
www.globenewswire.com - March 4 at 8:31 AM
Chronic Lymphocytic Leukemia Market, Forecast to 2025 - Roche, AstraZeneca, Verastem, Novartis, and AbbVie are Dominating - Yahoo FinanceChronic Lymphocytic Leukemia Market, Forecast to 2025 - Roche, AstraZeneca, Verastem, Novartis, and AbbVie are Dominating - Yahoo Finance
finance.yahoo.com - February 27 at 1:14 PM
BRIEF-Astrazeneca Says Divests Global Rights To Movantik - ReutersBRIEF-Astrazeneca Says Divests Global Rights To Movantik - Reuters
www.reuters.com - February 25 at 11:24 PM
Ex-Dividend Reminder: Brookfield Infrastructure Partners, AstraZeneca and Baxter International - NasdaqEx-Dividend Reminder: Brookfield Infrastructure Partners, AstraZeneca and Baxter International - Nasdaq
www.nasdaq.com - February 25 at 1:23 PM
AstraZeneca To Sublicense Worldwide Rights To Movantik To RedHill Biopharma - NasdaqAstraZeneca To Sublicense Worldwide Rights To Movantik To RedHill Biopharma - Nasdaq
www.nasdaq.com - February 25 at 1:23 PM
RedHill Biopharma Acquires Rights to Movantik® from AstraZeneca - BenzingaRedHill Biopharma Acquires Rights to Movantik® from AstraZeneca - Benzinga
www.benzinga.com - February 25 at 8:22 AM
Why It Might Not Make Sense To Buy AstraZeneca PLC (LON:AZN) For Its Upcoming Dividend - Yahoo FinanceWhy It Might Not Make Sense To Buy AstraZeneca PLC (LON:AZN) For Its Upcoming Dividend - Yahoo Finance
finance.yahoo.com - February 23 at 7:13 AM
Why It Might Not Make Sense To Buy AstraZeneca PLC (LON:AZN) For Its Upcoming DividendWhy It Might Not Make Sense To Buy AstraZeneca PLC (LON:AZN) For Its Upcoming Dividend
finance.yahoo.com - February 23 at 7:13 AM
BRIEF-Astrazeneca Pharma India Commences Launch Of QTERN In India - ReutersBRIEF-Astrazeneca Pharma India Commences Launch Of QTERN In India - Reuters
www.reuters.com - February 20 at 12:00 PM
Global Hospital Infection Therapeutics Market (2020 to 2025) - Key Players Include Merck & Co, Allergan & AstraZeneca Among Others - ResearchAndMarkets.com - Yahoo FinanceGlobal Hospital Infection Therapeutics Market (2020 to 2025) - Key Players Include Merck & Co, Allergan & AstraZeneca Among Others - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - February 19 at 3:53 PM
Here’s why Astrazeneca is one of the most expensive shares on the market - Yahoo Finance UKHere’s why Astrazeneca is one of the most expensive shares on the market - Yahoo Finance UK
uk.finance.yahoo.com - February 19 at 5:51 AM
NeoTX Closes $45 Million Series C FinancingNeoTX Closes $45 Million Series C Financing
finance.yahoo.com - February 19 at 5:51 AM
AstraZeneca Cautions on Coronavirus Impact, But Sees Solid 2020 Revenue Growth - TheStreetAstraZeneca Cautions on Coronavirus Impact, But Sees Solid 2020 Revenue Growth - TheStreet
www.thestreet.com - February 15 at 5:54 PM
AstraZeneca PLC (AZN) Q4 2019 Earnings Call Transcript - The Motley FoolAstraZeneca PLC (AZN) Q4 2019 Earnings Call Transcript - The Motley Fool
www.fool.com - February 15 at 5:54 PM
Astrazeneca CEO Pascal Soriot on earnings results, coronavirus impact and more - CNBCAstrazeneca CEO Pascal Soriot on earnings results, coronavirus impact and more - CNBC
www.cnbc.com - February 14 at 2:11 PM
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel